Status:
COMPLETED
Efficacy of Piroxicam as a Perioperative Analgesic for Patients Undergoing Fixation of Maxillofacial Fractures
Lead Sponsor:
Ain Shams University
Conditions:
Postoperative Pain
Eligibility:
All Genders
16-25 years
Phase:
EARLY_PHASE1
Brief Summary
At Eldemerdash Hospital at Ain Shams University in Egypt, 72 adult patients (16 to 25 years old) who had mandibular or maxillary fractures were treated with open reduction and internal stabilization. ...
Detailed Description
Patients were divided into two groups at random using a computer-generated list: the GA group received no piroxicam and the piroxicam group got a 0.4 mg/kg IM piroxicam induction. Both groups got IV p...
Eligibility Criteria
Inclusion
- patients aged from 16-25 years old
- ASAI II
- scheduled for open reduction and internal fixation of mandibular or maxillary fractures
Exclusion
- a history of convulsion,
- gastrodudenal ulcer
- hematological disorders
- patient suffering from hepatic or renal dysfunction
- concomitant use of anticoagulants
- refusal of the patients to participate
- patients younger than 12 years
Key Trial Info
Start Date :
August 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04062591
Start Date
August 16 2019
End Date
December 31 2022
Last Update
March 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams U
Cairo, Egypt, 11566